Psychedelics Optimi Health secures MDMA and psilocybin distribution agreement in Australia The company will supply Mind Medicine Australia with the substances, now considered designated therapies in the country Rowan DunneMarch 1, 2023
Psychedelics PharmAla Biotech signs agreement to sell clinical-grade MDMA in Australia Companies are running more MDMA and psilocybin trials after the Australian drug regulation changes Natalia Buendia CalvilloFebruary 14, 2023
Psychedelics Optimi Health submits clinical trial application after developing proprietary MDMA drug The drug will be used to help establish a safe supply for patients in Canada and Australia Rowan DunneFebruary 7, 2023
News Australia re-classifies MDMA and psilocybin to be prescribed as medicine Psychiatrists can now prescribe MDMA for the treatment of post-traumatic stress disorder and psilocybin for treatment-resistant depression Natalia Buendia CalvilloFebruary 3, 2023
Psychedelics Calgary’s ATMA launches psychedelic-assisted therapy training course for physicians The program's creation was inspired by new regulations for psychedelic-assisted therapy in Alberta Rowan DunneJanuary 27, 2023
Psychedelics PharmAla Biotech gets Health Canada approval to export large MDMA shipment to the U.K. The company believes this to be the largest shipment of MDMA the government department has ever approved Rowan DunneJanuary 24, 2023
Cannabis U.S. senators introduce bill to improve access to psilocybin and MDMA The bill would reduce 'unreasonably burdensome rules and regulations' Rowan DunneNovember 23, 2022
Canada PsyCan aims to be ‘go-to’ psychedelics industry organization, receives support from lawmakers The non-profit trade association received a high level of interest from multiple branches of government Rowan DunneNovember 10, 2022
International Psychedelic drugs market awaits nearly 100% revenue expansion by 2026 end: Fairfield The market researcher anticipates a 14.5% CAGR during the 2021-2026 forecast period Rowan DunneOctober 20, 2022
Psychedelics MindMed doses first patient with MDMA-like compounds in new trial New study will compare the effects of MDA and MDMA in humans for the first time Rowan DunneSeptember 20, 2022